Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:acquired_by |
gptkb:Biogen_Idec
|
| gptkbp:awards |
gptkb:Biotechnology_Innovation_Organization_Award
Top 100 Best Companies to Work For Innovator of the Year Award Best Places to Work in San Diego |
| gptkbp:clinical_trial |
Bexxar for non-Hodgkin lymphoma
Novel therapies for autoimmune diseases. Rituximab for rheumatoid arthritis Zevalin for lymphoma |
| gptkbp:community_involvement |
Partnerships with local universities.
Employee volunteer programs. Sponsorship of health awareness campaigns. Support for cancer research initiatives. |
| gptkbp:dissolved |
gptkb:2003
|
| gptkbp:financials |
Invested heavily in R& D.
Publicly traded on NASDAQ. Revenue in 2002 was approximately $1 billion. Market capitalization at acquisition was $6.5 billion. |
| gptkbp:focus |
oncology
autoimmune diseases |
| gptkbp:founded |
gptkb:1985
|
| gptkbp:founder |
gptkb:Howard_W._Robin
|
| gptkbp:headcount |
Diverse workforce.
Approximately 1,000 employees at peak. Global workforce. Strong emphasis on talent development. |
| gptkbp:headquarters |
gptkb:San_Diego,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Idec Pharmaceuticals
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:key_people |
gptkb:Howard_W._Robin
gptkb:James_C._Mc_Nerney gptkb:M._Christine_Carr |
| gptkbp:legacy |
Contributed to the growth of the biotech industry.
Paved the way for future biotech innovations. Set standards for biotech acquisitions. Influential in the development of monoclonal antibodies. |
| gptkbp:location |
gptkb:United_States
|
| gptkbp:notable_achievements |
Pioneered the development of antibody-drug conjugates.
Contributed to the advancement of personalized medicine. Developed therapies for chronic lymphocytic leukemia. First monoclonal antibody approved for non-Hodgkin lymphoma. |
| gptkbp:partnerships |
gptkb:Genentech
gptkb:Amgen gptkb:Abb_Vie |
| gptkbp:products |
gptkb:Bexxar
gptkb:Zevalin gptkb:Rituxan |
| gptkbp:region |
Worldwide
|
| gptkbp:research_focus |
biologics
small molecules therapeutic antibodies |
| gptkbp:subsidiary |
gptkb:Biogen_Inc.
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
www.idecpharma.com
|
| gptkbp:bfsParent |
gptkb:Biogen_Idec
|
| gptkbp:bfsLayer |
5
|